174 related articles for article (PubMed ID: 16458962)
21. Relationship between ARLTS1 polymorphisms and risk of chronic lymphocytic leukemia.
Sellick GS; Catovsky D; Houlston RS
Leuk Res; 2006 Dec; 30(12):1573-6. PubMed ID: 16581122
[TBL] [Abstract][Full Text] [Related]
22. Effect of the p53 codon 72 and intron 3 polymorphisms on non-small cell lung cancer (NSCLC) prognosis.
Boldrini L; Gisfredi S; Ursino S; Lucchi M; Greco G; Mussi A; Donati V; Fontanini G
Cancer Invest; 2008 Mar; 26(2):168-72. PubMed ID: 18259947
[TBL] [Abstract][Full Text] [Related]
23. Expression of p53 gene in B-CLL peripheral lymphocytes.
Gandini D; Moretti S; Latorraca A; Lanza F; del Senno L
Boll Soc Ital Biol Sper; 1992 Oct; 68(10):597-600. PubMed ID: 1363520
[TBL] [Abstract][Full Text] [Related]
24. Susceptibility genes and B-chronic lymphocytic leukaemia.
Slager SL; Kay NE; Fredericksen ZS; Wang AH; Liebow M; Cunningham JM; Vachon CM; Call TG; Cerhan JR
Br J Haematol; 2007 Dec; 139(5):762-71. PubMed ID: 18021089
[TBL] [Abstract][Full Text] [Related]
25. Interleukin-1B (IL1B) and interleukin-6 (IL6) gene polymorphisms are associated with risk of chronic lymphocytic leukaemia.
Ennas MG; Moore PS; Zucca M; Angelucci E; Cabras MG; Melis M; Gabbas A; Serpe R; Madeddu C; Scarpa A; Cocco P
Hematol Oncol; 2008 Jun; 26(2):98-103. PubMed ID: 18271063
[TBL] [Abstract][Full Text] [Related]
26. [TP53 codon 72 polymorphism and gastric cancer risk: a case-control study in individuals from the central-western region of Venezuela].
Cañas M; Morán Y; Camargo ME; Rivero MB; Bohórquez A; Villegas V; Ramírez E; Rendón Y; Suárez A; Morales L; Useche E; Salazar S; Zambrano A; Ramírez A; Valderrama E; Briceño Z; Chiurillo MA
Invest Clin; 2009 Jun; 50(2):153-61. PubMed ID: 19662811
[TBL] [Abstract][Full Text] [Related]
27. Frequency of TP53 mutations in relation to Arg72Pro genotypes in non small cell lung cancer.
Lind H; Ekstrøm PO; Ryberg D; Skaug V; Andreassen T; Stangeland L; Haugen A; Zienolddiny S
Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2077-81. PubMed ID: 17932356
[TBL] [Abstract][Full Text] [Related]
28. Detection of p53 dysfunction by flow cytometry in chronic lymphocytic leukaemia.
Carter A; Lin K; Sherrington PD; Pettitt AR
Br J Haematol; 2004 Nov; 127(4):425-8. PubMed ID: 15521919
[TBL] [Abstract][Full Text] [Related]
29. Association of p53 polymorphism with ICSI/IVF failure and recurrent pregnancy loss.
Firouzabadi RD; Ghasemi N; Rozbahani MA; Tabibnejad N
Aust N Z J Obstet Gynaecol; 2009 Apr; 49(2):216-9. PubMed ID: 19432615
[TBL] [Abstract][Full Text] [Related]
30. Prognostic impact of p53 Pro72 homozygous genotype in non-small cell lung cancer patients.
Boldrini L; Gisfredi S; Ursino S; Lucchi M; Greco G; Mussi A; Fontanini G
Oncol Rep; 2008 Mar; 19(3):771-3. PubMed ID: 18288414
[TBL] [Abstract][Full Text] [Related]
31. TP53 Gene 72 Arg/Pro (rs1042522) Single Nucleotide Polymorphism Contribute to Increase the Risk of B-Chronic Lymphocytic Leukemia in the Sudanese Population.
Mohammed Basabaeen AA; Abdelgader EA; Babekir EA; Abdelrahim SO; Eltayeb NH; Altayeb OA; Fadul EA; Sabo A; Ibrahim IK
Asian Pac J Cancer Prev; 2019 May; 20(5):1579-1585. PubMed ID: 31128065
[TBL] [Abstract][Full Text] [Related]
32. TP53 codon 72 polymorphism in patients with chronic myeloid leukemia.
Bergamaschi G; Merante S; Orlandi E; Galli A; Bernasconi P; Cazzola M
Haematologica; 2004 Jul; 89(7):868-9. PubMed ID: 15257943
[TBL] [Abstract][Full Text] [Related]
33. 172G>T variant in the 5' untranslated region of DNA repair gene RAD51 reduces risk of squamous cell carcinoma of the head and neck and interacts with a P53 codon 72 variant.
Lu J; Wang LE; Xiong P; Sturgis EM; Spitz MR; Wei Q
Carcinogenesis; 2007 May; 28(5):988-94. PubMed ID: 17118968
[TBL] [Abstract][Full Text] [Related]
34. The cyclin D1 alternative transcripts [a] and [b] are expressed in normal and malignant lymphocytes and their relative levels are influenced by the polymorphism at codon 241.
Howe D; Lynas C
Haematologica; 2001 Jun; 86(6):563-9. PubMed ID: 11418364
[TBL] [Abstract][Full Text] [Related]
35. A TP53 polymorphism is associated with increased risk of colorectal cancer and with reduced levels of TP53 mRNA.
Gemignani F; Moreno V; Landi S; Moullan N; Chabrier A; Gutiérrez-Enríquez S; Hall J; Guino E; Peinado MA; Capella G; Canzian F
Oncogene; 2004 Mar; 23(10):1954-6. PubMed ID: 14647431
[TBL] [Abstract][Full Text] [Related]
36. Germline TP53 mutations and single nucleotide polymorphisms in children.
Valva P; Becker P; Streitemberger P; Lombardi GM; Rey G; Guzman CA; Preciado MV
Medicina (B Aires); 2009; 69(1 Pt 2):143-7. PubMed ID: 19414295
[TBL] [Abstract][Full Text] [Related]
37. Mutated and non-mutated TP53 as targets in the treatment of leukaemia.
Nahi H; Selivanova G; Lehmann S; Möllgård L; Bengtzen S; Concha H; Svensson A; Wiman KG; Merup M; Paul C
Br J Haematol; 2008 May; 141(4):445-53. PubMed ID: 18341636
[TBL] [Abstract][Full Text] [Related]
38. DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy.
Quintela-Fandino M; Hitt R; Medina PP; Gamarra S; Manso L; Cortes-Funes H; Sanchez-Cespedes M
J Clin Oncol; 2006 Sep; 24(26):4333-9. PubMed ID: 16896002
[TBL] [Abstract][Full Text] [Related]
39. Polymorphism in the P2X7 receptor gene and survival in chronic lymphocytic leukaemia.
Thunberg U; Tobin G; Johnson A; Söderberg O; Padyukov L; Hultdin M; Klareskog L; Enblad G; Sundström C; Roos G; Rosenquist R
Lancet; 2002 Dec; 360(9349):1935-9. PubMed ID: 12493261
[TBL] [Abstract][Full Text] [Related]
40. The prognostic value of TP53 mutations in chronic lymphocytic leukemia is independent of Del17p13: implications for overall survival and chemorefractoriness.
Rossi D; Cerri M; Deambrogi C; Sozzi E; Cresta S; Rasi S; De Paoli L; Spina V; Gattei V; Capello D; Forconi F; Lauria F; Gaidano G
Clin Cancer Res; 2009 Feb; 15(3):995-1004. PubMed ID: 19188171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]